You searched for "medication"
In conversation with Ulrik Pedersen, Chairman of the EBEORL-HNS Exam Board
The European Examination Board in Otorhinolaryngology was created in 2008 in order to ‘harmonise the knowledge base among otorhinolaryngolgists throughout Europe’. Declan Costello spoke to new Chairman of the Board, Ulrik Pedersen. Ulrik Pedersen. Congratulations on your appointment as the...Global audiology during COVID-19
The COVID-19 pandemic has affected, and in some areas, put a complete hold on, audiology practice around the world. In April 2020, during the peak of the pandemic for many regions, our audiology Global Ambassadors provided their reports from their...A surgeon’s perspective on the challenges facing cochlear implantation in children
Cochlear implantation in children offers a different set of challenges and goals to adult practice. In this article, Iain Bruce, Professor of Paediatric Otolaryngology in Manchester, UK, explains some of the current clinical and research challenges in paediatric cochlear implantation,...
Diagnosis and treatment of snoring in adults – S2k Guideline of the German Society of Otorhinolaryngology, Head and Neck Surgery
This article summarises the work done by the German Society of Otorhinolaryngology, who have developed guidelines for the management of snoring. ‘S2k’ is German nomenclature for a consensus based guideline, which (for those of you interested in such things), is...
Is surgery in obese children with obstructive sleep apnoea effective?
The authors present the results of their literature review and meta-analysis of studies examining adenotonsillectomy, uvulopalatopharyngoplasty (UPPP), supraglottoplasty, tongue base surgery or a combination in obese children with obstructive sleep apnoea (OSA). The one study investigating effects of UPPP was...
Cochlear implantation in asymmetric hearing loss
Criteria for cochlear implantation (CI) is a constant topic of debate. The UK traditionally had relatively restrictive guidance, although this has been greatly improved by more recent guidance released in 2019. Nevertheless, because of the lack of evidence for cost-effectiveness,...
